Masters of Health Magazine November 2026 | Page 32

Because We Can, Should We?

A recently published Nature study from Stanford University raises profound scientific, ethical, and regulatory questions about how far genetic engineering and human-animal neural research should be permitted to advance.

The study describes a process the researchers call xenocortication. Scientists genetically altered mice so that most of their neocortices and hippocampi were developmentally depleted, creating a biological space into which human cortical organoids could be transplanted. The human-derived neural tissue subsequently grew, organized, connected extensively with the mouse nervous system, demonstrating coordinated electrical activity.

This represents a remarkable technical achievement. It also demands a serious conversation about scientific boundaries.

What Is Xenocortication?

The word itself deserves examination. Xeno means foreign or originating from another species; cortic refers to the cerebral cortex; and -ation denotes a process. In practical terms, xenocortication describes the creation of cortical tissue within one species using tissue derived from another.

In this experiment, human-derived cortical tissue was transplanted into mice whose native cortical development had been significantly depleted. By three months, the human-derived xenocortical graft constituted approximately 91.9% of the combined cortical tissue volume in the animals measured.

This was not simply human neural tissue surviving in a laboratory dish. Human neurons were given a foreign territory within a living animal, where they could mature, organize, establish connections with the host nervous system, and become electrophysiologically active.  That distinction matters.

Scientific Achievement and Ethical Boundaries

The experiment also raises significant animal-welfare questions. The cortex-depleted animals required modified care, including changes in feeding, weaning, and maternal support. The investigators also reported culling the majority of pups with intact cortices in some litters to reduce competition for resources and improve survival of the cortex-depleted animals. 

Removing the brains of one species to be replaced with another has moved into the world of Shelley’s 1818 novel, Frankenstein.  The inventor, Victor, could not predict what his creation would become.  Similarly, with xenocortication, researchers can specify the genetics, but the resulting neural network is partly self-organizing.  The implication is not necessarily sinister.  However, it means that complex biological systems can exhibit properties that aren’t completely specified by the engineering inputs. 

To their credit, the investigators recognized that the work entered ethically uncertain territory. They consulted bioethicists, obtained animal-care and stem-cell research oversight, utilized an external independent ethics committee, and considered the possibility that the animals could develop altered capacities.

Yet this raises a larger question: Are our ethical and regulatory frameworks advancing as rapidly as our capacity to engineer novel biological systems?

Ethical approval establishes that an experiment meets the requirements of an existing oversight framework. It does not necessarily answer the larger societal question of whether the framework itself is adequate for technologies that did not exist when many of our ethical boundaries were conceived.

Genetic Engineering and Scientific Arrogance

Michelle Perro, MD

Dr. Michelle Perro, MD, Pediatrician

"Knowledge isn’t power until it is applied."

~ Dale Carnegie